טוען...

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening

BACKGROUND: The indicating FTA card is a dry medium used for collection of cervical samples. HPVIR is a multiplex real-time PCR test that detects 12 high-risk human papillomavirus types (hrHPV) and provides single genotype information for HPV16, − 31, − 35, − 39, − 51, − 56, and − 59 and pooled type...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Virol J
Main Authors:	Gustavsson, Inger, Aarnio, Riina, Myrnäs, Mattias, Hedlund-Lindberg, Julia, Taku, Ongeziwe, Meiring, Tracy, Wikström, Ingrid, Enroth, Stefan, Williamson, Anna-Lise, Olovsson, Matts, Gyllensten, Ulf
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BioMed Central 2019
נושאים:	Research
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6704622/ https://ncbi.nlm.nih.gov/pubmed/31438976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-019-1216-7
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening

פריטים דומים